![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Primary Biliary Cholangitis - 29 Studies Found
Recruiting |
: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid : Primary Biliary Cholangitis (PBC) : 2017-03-28 :
|
Recruiting |
: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid : Primary Biliary Cholangitis : 2017-03-24 :
|
Not yet recruiting |
: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis : Primary Biliary Cholangitis : 2017-05-11 : Drug: APD334 APD334 active treatment for 24 weeks. O |
Recruiting |
: Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis : Primary Biliary Cholangitis : 2016-06-13 :
|
Recruiting |
: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) : Primary Biliary Cirrhosis : 2016-11-02 :
|
Recruiting |
: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients : Primary Biliary Cholangitis : 2015-08-04 :
|
Active, not recruiting |
: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis : Primary Biliary Cirrhosis : 2015-12-19 |
Not yet recruiting |
: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS) : Primary Biliary Cirrhosis : 2017-04-10 :
|
Completed |
: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2006-08-15 : Drug: rituximab rituximab 1000 mg IV day 1 and 15, given over 5 - 6 hours |
Completed |
: Moexipril for Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2007-12-22 : Drug: Moexipril Moexipril was given at a starting dose of 7.5 mg daily for 1 week to all enrolled patien |